Match!
Shanthi Mendis
World Health Organization
Physical therapyDiseaseStrokeMedicineEnvironmental health
77Publications
35H-index
6,665Citations
What is this?
Publications 77
Newest
• Progress in prevention and control of noncommunicable diseases (NSD) is lagging behind in many countries.
2 CitationsSource
#1Sherry L. Grace (Toronto Rehabilitation Institute)H-Index: 42
#2Karam I. Turk-Adawi (York University)H-Index: 7
Last. Nizal Sarrafzadegan (IUMS: Isfahan University of Medical Sciences)H-Index: 44
view all 15 authors...
Objective Cardiovascular disease is a global epidemic, which is largely preventable. Cardiac rehabilitation (CR) is demonstrated to be cost-effective and efficacious in high-income countries. CR could represent an important approach to mitigate the epidemic of cardiovascular disease in lower-resource settings. The purpose of this consensus statement was to review low-cost approaches to delivering the core components of CR, to propose a testable model of CR which could feasibly be delivered in mi...
31 CitationsSource
#1Ralph L. SaccoH-Index: 126
#2Gregory A. RothH-Index: 52
Last. William A. ZoghbiH-Index: 52
view all 18 authors...
In 2011, the United Nations set key targets to reach by 2025 to reduce the risk of premature noncommunicable disease death by 25% by 2025. With cardiovascular disease being the largest contributor to global mortality, accounting for nearly half of the 36 million annual noncommunicable disease deaths, achieving the 2025 goal requires that cardiovascular disease and its risk factors be aggressively addressed. The Global Cardiovascular Disease Taskforce, comprising the World Heart Federation, Ameri...
35 CitationsSource
#1Ralph L. SaccoH-Index: 126
#2Gregory A. RothH-Index: 52
Last. William A. ZoghbiH-Index: 52
view all 18 authors...
Source
Source
#1Mathu SelvarajahH-Index: 1
#2Shanthi MendisH-Index: 35
Last. Firdosi R MehtaH-Index: 2
view all 6 authors...
Introduction: A double blind placebo controlled randomized trial was conducted to investigate the effect of angiotensin-converting-enzyme (ACE) inhibitor enalapril on the progression of Chronic Kidney Disease (CKD) caused by chronic exposure to nephrotoxins. Methods: 263 people aged 18-70 years diagnosed with CKD stages I, II or III who were not taking ACE inhibitors, who had no other chronic disease or contraindication for treatment with ACE inhibitors, were randomly assigned to enalapril or pl...
2 CitationsSource
#1Ralph L. SaccoH-Index: 126
#2Gregory A. RothH-Index: 52
Last. William A. ZoghbiH-Index: 52
view all 18 authors...
In 2011, the United Nations set key targets to reach by 2025 to reduce the risk of premature noncommunicable disease death by 25% by 2025. With cardiovascular disease being the largest contributor to global mortality, accounting for nearly half of the 36 million annual noncommunicable disease deaths, achieving the 2025 goal requires that cardiovascular disease and its risk factors be aggressively addressed. The Global Cardiovascular Disease Taskforce, comprising the World Heart Federation, Ameri...
5 CitationsSource
#1Shanthi MendisH-Index: 35
#2Oleg ChestnovH-Index: 6
Source
#1Ralph L. SaccoH-Index: 126
#2Gregory A. RothH-Index: 52
Last. Shanthi MendisH-Index: 35
view all 18 authors...
4 CitationsSource
#1Joseph T. Knapper (Emory University)H-Index: 8
#2Nima Ghasemzadeh (Emory University)H-Index: 14
Last. Laurence S. Sperling (Emory University)H-Index: 34
view all 9 authors...
Despite numerous groundbreaking advances in the field, cardiovascular disease remains the leading cause of mortality in the United States, accounting for more than 787,000 deaths per year. Already leading the world in per capita healthcare expenditure, U.S. medical costs related to cardiovascular disease are projected to triple by 2030, to over $800 billion annually. The medical community’s traditional disproportionate focus on treating cardiovascular disease, relative to promoting cardiovascula...
10 CitationsSource
12345678